Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cell Biol ; 39(23)2019 12 01.
Article in English | MEDLINE | ID: mdl-31548262

ABSTRACT

The enhancer/promoter of the vitellogenin II gene (VTG) has been extensively studied as a model system of vertebrate transcriptional control. While deletion mutagenesis and in vivo footprinting identified the transcription factor (TF) binding sites governing its tissue specificity, DNase hypersensitivity and DNA methylation studies revealed the epigenetic changes accompanying its hormone-dependent activation. Moreover, upon induction with estrogen (E2), the region flanking the estrogen-responsive element (ERE) was reported to undergo active DNA demethylation. We now show that although the VTG ERE is methylated in embryonic chicken liver and in LMH/2A hepatocytes, its induction by E2 was not accompanied by extensive demethylation. In contrast, E2 failed to activate a VTG enhancer/promoter-controlled luciferase reporter gene methylated by SssI. Surprisingly, this inducibility difference could be traced not to the ERE but rather to a single CpG in an E-box (CACGTG) sequence upstream of the VTG TATA box, which is unmethylated in vivo but methylated by SssI. We demonstrate that this E-box binds the upstream stimulating factor USF1/2. Selective methylation of the CpG within this binding site with an E-box-specific DNA methyltransferase, Eco72IM, was sufficient to attenuate USF1/2 binding in vitro and abolish the hormone-induced transcription of the VTG gene in the reporter system.


Subject(s)
Ectopic Gene Expression/genetics , Estrogen Receptor alpha/genetics , Vitellogenins/genetics , Animals , Binding Sites , Cell Line , Chick Embryo , CpG Islands/genetics , DNA Methylation/genetics , DNA-Binding Proteins/metabolism , DNA-Cytosine Methylases/metabolism , Ectopic Gene Expression/drug effects , Estrogen Receptor alpha/metabolism , Estrogens/metabolism , Gene Expression Regulation/drug effects , Genes, Reporter , Humans , Promoter Regions, Genetic/drug effects , Promoter Regions, Genetic/genetics , Regulatory Sequences, Nucleic Acid , Transcription Factors/metabolism , Vitellogenins/metabolism
2.
Nucleic Acids Res ; 44(6): 2691-705, 2016 Apr 07.
Article in English | MEDLINE | ID: mdl-26743004

ABSTRACT

During class switch recombination (CSR), antigen-stimulated B-cells rearrange their immunoglobulin constant heavy chain (CH) loci to generate antibodies with different effector functions. CSR is initiated by activation-induced deaminase (AID), which converts cytosines in switch (S) regions, repetitive sequences flanking the CH loci, to uracils. Although U/G mispairs arising in this way are generally efficiently repaired to C/Gs by uracil DNA glycosylase (UNG)-initiated base excision repair (BER), uracil processing in S-regions of activated B-cells occasionally gives rise to double strand breaks (DSBs), which trigger CSR. Surprisingly, genetic experiments revealed that CSR is dependent not only on AID and UNG, but also on mismatch repair (MMR). To elucidate the role of MMR in CSR, we studied the processing of uracil-containing DNA substrates in extracts of MMR-proficient and -deficient human cells, as well as in a system reconstituted from recombinant BER and MMR proteins. Here, we show that the interplay of these repair systems gives rise to DSBs in vitro and to genomic deletions and mutations in vivo, particularly in an S-region sequence. Our findings further suggest that MMR affects pathway choice in DSB repair. Given its amenability to manipulation, our system represents a powerful tool for the molecular dissection of CSR.


Subject(s)
B-Lymphocytes/metabolism , DNA Mismatch Repair/immunology , DNA/genetics , Immunoglobulin Class Switching/genetics , Immunoglobulin Constant Regions/genetics , Uracil/metabolism , B-Lymphocytes/cytology , B-Lymphocytes/immunology , Cell Line, Tumor , Cytidine Deaminase/genetics , Cytidine Deaminase/immunology , Cytosine/immunology , Cytosine/metabolism , DNA/immunology , DNA Breaks, Double-Stranded , Gene Expression Regulation , HEK293 Cells , Humans , Signal Transduction , Uracil/immunology , Uracil-DNA Glycosidase/genetics , Uracil-DNA Glycosidase/immunology
3.
DNA Repair (Amst) ; 28: 1-7, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25697728

ABSTRACT

The cytotoxicity of SN1-type alkylating agents such as N-methyl-N'-nitrosourea (MNU), N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), or the cancer chemotherapeutics temozolomide, dacarbazine and streptozotocin has been ascribed to the persistence of O(6)-methylguanine ((me)G) in genomic DNA. One hypothesis posits that (me)G toxicity is caused by futile attempts of the mismatch repair (MMR) system to process (me)G/C or (me)G/T mispairs arising during replication, while an alternative proposal suggests that the latter lesions activate DNA damage signaling, cell cycle arrest and apoptosis directly. Attempts to elucidate the molecular mechanism of (me)G-induced cell killing in vivo have been hampered by the fact that the above reagents induce several types of modifications in genomic DNA, which are processed by different repair pathways. In contrast, defined substrates studied in vitro did not undergo replication. We set out to re-examine this phenomenon in replication-competent Xenopus laevis egg extracts, using either phagemid substrates containing a single (me)G residue, or methylated sperm chromatin. Our findings provide further support for the futile cycling hypothesis.


Subject(s)
DNA Damage , DNA Mismatch Repair/physiology , DNA/metabolism , Guanine/analogs & derivatives , Animals , Cell Extracts , DNA/chemistry , DNA Replication , Guanine/metabolism , Ovum/metabolism , Xenopus laevis
SELECTION OF CITATIONS
SEARCH DETAIL
...